GlassScriptPhysician profile
Hassan Mostafa
NPI 1174939003
$2,555.92
in general payments reported to CMS, 2019-2025
25 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.43 · 2021: $29.58 · 2022: $628 · 2023: $1,596 · 2024: $139 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788 · Education: $98.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,787.77 |
| Education | $98.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $609.47 | 2022-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novartis Pharmaceuticals Corporation | $417.76 | 2022-2023 | |
| Boston Scientific Corporation | $326.45 | 2021-2024 | Varithena Administration Pack, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $218.99 | 2022-2023 | Eliquis |
| Abbott Laboratories | $160.59 | 2022-2025 | Cardiomems |
| Philips North America LLC | $155.32 | 2022-2024 | (Ck4) Mcot |
| Pfizer INC. | $117.61 | 2022-2023 | |
| Actelion Pharmaceuticals US, INC. | $98.99 | 2023 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.33 | 2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $61.23 | 2022-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $41.57 | 2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $40.39 | 2022-2023 | Farxiga |
| Abiomed | $34.07 | 2023 | Impella |
| Bayer Healthcare Pharmaceuticals INC. | $30.89 | 2023 | |
| Alnylam Pharmaceuticals INC. | $28.80 | 2023 | Amvuttra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.55 | 2024 | Lifevest |
| Penumbra, INC. | $16.61 | 2022 | |
| Chiesi USA, INC. | $16.45 | 2022 | |
| Angiodynamics, INC. | $16.30 | 2024 | Auryon Laser System 100-120 Vac |
| Bardy Diagnostics, INC. | $15.35 | 2022 | |
| Amgen INC. | $15.32 | 2022 | |
| Teleflex LLC | $14.25 | 2022 | |
| Baxter Healthcare | $13.29 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $11.91 | 2022 | |
| Astellas Pharma US INC | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hassan Mostafa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.